Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Supreme Court Allows Forensic Audit in Daiichi-Fortis Arbitration Enforcement Dispute

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Supreme Court Allows Forensic Audit in Daiichi-Fortis Arbitration Enforcement Dispute

Analysed 25 Sept 2026·3 sources analysed·Goa, India·Business
Supreme Court Allows Forensic Audit in Daiichi-Fortis Arbitration Enforcement DisputePreviousNext

The Supreme Court upheld Delhi High Court orders permitting a forensic audit of Fortis Healthcare's transactions linked to Daiichi Sankyo's efforts to enforce a 2016 arbitral award against former Fortis promoters Malvinder and Shivinder Singh. The Court did not assess the merits but emphasized the audit's independence from the High Court's tentative observations. The dispute arises from Daiichi's arbitration over the Singh brothers' sale of their Ranbaxy stake, with enforcement proceedings extending to Fortis-related transactions.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 59/100.

Outlets measured: businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 25 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 25 Sept, 10:18 am. Other outlets followed.

25 Sept, 10:18 am2 sources · 5 h25 Sept, 02:56 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Decathlon India Targets Rs 1,000 Crore Running Business with KIPRUN Brand by 2030
Next →
Kian-M Export Files IPO Papers with Sebi to Raise Rs 500 Crore
1
economictimes25 Sept, 10:18 am
Supreme Court backs Delhi HC orders in Daiichi-Fortis dispute, clears way for forensic audit
  • 2
    businessstandard25 Sept, 02:56 pm
    SC allows forensic audit of Fortis deals in Daiichi-Singh brothers row
  • Accountability flags

    TBN's analysis identified the following accountability dimensions in this story.

    • financial irregularity

      This story involves alleged financial misconduct — unexplained transactions, procurement irregularities, or misuse of public/shareholder funds.

    Who's involved

    Institutions and figures named across source coverage.

    Government
    Delhi High CourtSupreme Court of India
    Corporate
    Fortis Healthcare LimitedRanbaxy LaboratoriesIHH Healthcare BerhadDaiichi SankyoDaiichi Sankyo Company LimitedRHT Health TrustFortis Healthcare
    Judiciary
    Delhi High CourtSupreme Court of India

    Story context

    Category
    Business
    Location
    Goa, India
    Sources analysed
    3
    Last analysed
    25 Sept 2026
    Key entities
    Delhi High CourtSupreme Court of IndiaFortis HealthcareAuditAbhishek SinghviRanbaxy LaboratoriesForensic scienceChief Justice of IndiaDaiichi SankyoJapanJudgment debtorPublic company